(Q42851158)

English

The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and

scientific article published on October 2010

Statements

The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and (English)
Interventional Cardiologists of the Thoraxcenter

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit